台股 » 個股 » 智擎 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智擎

(4162)
可現股當沖
  • 股價
    88.3
  • 漲跌
    ▼1.1
  • 漲幅
    -1.23%
  • 成交量
    189
  • 產業
    上櫃 生技醫療類股
  • 302人加入追蹤

    立即追蹤

  • 本地時間:13:35(已收盤)

     
智擎 (4162)籌碼相關-港商法國興業 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

港商法國興業 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/08/2000.002085.6285.80-20742-2.69%
2024/08/0800.00686.1085.40-6799-0.75%
2024/08/072686.5800.0086.70267943.27%
2024/07/29595.3400.0094.5057360.68%
2024/07/262396.3900.0097.60237293.15%
2024/03/08298.40298.1095.1001,9240.00%
2023/11/2821103.5200.00101.50214,2580.49%
2023/11/102109.002108.50106.5003,9260.00%
2023/10/264112.004108.38107.5002,0010.00%
2023/10/244109.004110.00110.0001,5450.00%
2023/10/122095.3400.0095.00209852.03%
2023/10/1119095.390.593.1095.20189.598919.16% 大買/鉅額交易
2023/10/05187.7000.0087.7019220.11%
2023/10/03387.7300.0086.8039790.31%
2023/09/182387.9600.0087.60231,0602.17%
2023/09/152785.7900.0086.50271,0332.61%
2023/09/131284.2800.0084.50121,0431.15%
2023/09/011489.3500.0089.10141,0711.31%
2023/08/16281.5000.0087.0021,0940.18%
2023/08/091084.9400.0084.90101,0900.92%
2023/01/307113.5700.00112.00711,9240.06%
2022/10/0300.0013114.50107.50-1315,465-0.08%
2022/09/2300.009140.50128.50-913,976-0.06%
2022/07/211292.1400.0092.70125,9550.20%
2022/07/1300.00791.2794.60-75,583-0.13%
2022/06/1300.001079.4977.80-104,958-0.20%
2022/06/0200.002071.6371.10-205,579-0.36%
2022/05/2700.001672.9972.80-166,174-0.26%
2022/05/2600.002272.8872.00-226,223-0.35%
2022/05/2500.007774.3474.40-776,314-1.22%
2022/05/1900.003475.5375.70-346,463-0.53%
2022/05/1300.005277.6077.30-526,402-0.81%
2022/05/0900.004084.3583.70-406,226-0.64%
2022/04/2700.009383.8084.60-935,889-1.58%
2022/03/227192.6400.0094.20713,2782.17%
2022/03/011977.8500.0078.00191,1751.62%
2022/01/06968.7900.0068.7097351.22%
2021/12/1400.007163.3063.10-71475-14.95%
2021/11/3018257.51100.257.1257.6081.835123.23% 大買/
2021/11/231157.6800.0057.10112943.74%
2021/11/18956.4100.0056.7092873.13%
2021/11/161056.7900.0056.20102803.57%
2021/11/12457.4800.0057.0042881.39%
2021/09/07561.2600.0061.2054221.18%
2021/04/22672.3000.0070.3061,7570.34%
2021/03/0800.00371.4071.40-31,066-0.28%
2021/02/2600.0011976.6876.10-119964-12.33% 大賣/鉅額交易
2021/02/1800.005649.9850.40-56560-9.98%
2021/02/1700.007049.2249.05-70554-12.63%
2020/05/2900.002673.5072.30-261,371-1.90%
2020/03/253539.8900.0039.60358374.18%
2019/08/1600.001272.3972.10-12781-1.54%
2019/08/08269.9000.0069.9026300.32%
2019/07/2200.001790.1890.00-17518-3.27%
2019/07/1800.001592.1491.50-15505-2.97%
2019/07/0800.001091.2591.30-10488-2.05%
2019/07/0200.002091.9191.70-20546-3.66%
2019/06/2000.002191.3593.00-21541-3.88%
2019/06/0400.001088.3388.30-10601-1.66%
2019/06/0300.00988.2789.20-9669-1.34%
2019/05/281090.9400.0092.20107901.26%
2019/05/2700.001288.5488.50-12792-1.51%
2019/01/093113.0000.00113.0036050.50%
2019/01/0312110.4600.00110.00126221.93%
2018/08/318134.0000.00134.0081,3170.61%
2018/06/1900.00209.4138.41136.00-209.41,082-19.35% 大賣/鉅額交易
2018/06/1500.00152143.51143.50-1521,062-14.30% 大賣/鉅額交易
2018/02/0500.005141.00142.00-5762-0.66%
2018/02/013148.5000.00146.5037890.38%
2018/01/1600.0059157.29154.50-59949-6.21%
智擎明、後年新藥將有斬獲 歐洲藥證+一期臨床數據結果Anue鉅亨-2023/11/03
智擎 相關文章